Medical Technology

With an aging population, the demand for healthcare in general and medical device technologies in particular continues to grow. Companies developing innovative medical device technologies serving large unmet clinical needs offer compelling investment returns. Their patent-protected products can achieve rapid revenue growth and attractive gross margins over extended periods of time.

Today's financing environment has created a growing number of later stage medical device opportunities due to:

• The large number of medical device companies funded in the earlier part of the decade
• Liquidity constraints created by the lack of an IPO market and few M&A exits
• The resulting need to finance companies longer
• A growing number of venture funds are capital constrained or near the end of their terms

We believe that some therapeutic areas are more attractive than others from an investment standpoint. Specifically, we focus our investing activities on medical technology companies that are developing proprietary medical devices for treating unmet clinical needs in high value therapeutic areas such as vascular diseases, diabetes, spine, stroke prevention, obesity and treatment of pulmonary disease.

See our Medical Technology portfolio companies